VMPL New Delhi [India] January 31 Allergic rhinitis is a very common condition often termed as hay fever which affects millions of people globally This chronic condition arises from the reaction of th ...

Diag-Nose Team Photo RhinoMAP platform Diag-Nose secures $2M to advance AI in respiratory care, aiming to optimize global <a target= ...

Diag-Nose.io sets new standards in respiratory care with AI and proteomics after a $2M seed funding success, now expanding to ...

Diag-Nose.io launches Houston office to advance precise respiratory care using AI and proteomics after a successful $2M seed ...

SNY misses Q4 earnings and sales estimates. It expects earnings growth to rebound in 2025. It plans to buy back shares worth 5 billion euro in 2025.

The Allan Labor Government is backing local medical technology startup Diag-Nose Medical to develop new treatments for chronic respiratory disorders ...

GSK plc GSK recently announced that EMA has accepted the regulatory filing seeking approval for its IL-5 inhibitor ...

The global sinusitis treatment market is witnessing steady growth, fueled by the increasing prevalence of sinus infections, ...

GSK announces depemokimab applications accepted for review in China and Japan for asthma with type 2 inflammation and CRSwNP: London, UK Wednesday, January 29, 2025, 17:00 Hrs [IS ...

London: GSK plc has announced that the European Medicines Agency (EMA) has accepted for review the Marketing Authorisation Application for the use of depemokimab in two indications.The ...

EMA accepts for review GSK’s MAA for depemokimab for use in asthma with type 2 inflammation and CRSwNP: London, UK Wednesday, January 29, 2025, 09:00 Hrs [IST] GSK plc announced ...

A Victorian-based company is using AI to help “map” and personalise the best treatment for patients with respiratory ...